Case report highlights goblet cell adenocarcinoma's unique diagnosis and management using immunohistochemistry.
Goblet cell adenocarcinoma (GCA) of the appendix is a unique entity newly introduced in the 2019 WHO Classification of Digestive Tumours. It is a rare and aggressive type of primary appendiceal adenocarcinoma showing amphicrine differentiation with goblet-like mucinous cells and variable numbers of endocrine cells and Paneth-like cells. A 49-year-old man was found to have an incidental mass after presenting with acute appendicitis and undergoing a routine appendicectomy. Histology showed small tubules and clusters of atypical cells circumferentially infiltrating into the wall of the appendix without a stromal reaction. There was a characteristic mix of mucinous, endocrine and Paneth-like cells with mild nuclear atypia and infrequent mitoses. Immunohistochemistry showed positivity for cytokeratin AE1/AE3, and neuroendocrine markers, including synaptophysin and CD56. Recommended management is generally a right hemicolectomy, although due to its rarity, there are no well-established consensus guidelines for management of GCA. In summary, GCA is a rare and aggressive primary appendiceal neoplasm exhibiting both mucinous and neuroendocrine differentiation with a characteristic histological appearance for diagnosis, albeit often a surprise finding. This case aims to highlight this unique entity and enrich the current knowledge base regarding GCAs.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: